A clinical trial to evaluate the effect of Shatavari ghrita on fetal outcome w.s.r. to birth weight

INTERVENTION: Intervention1: Shatavari Ghrita along with routine antenatal care: Shatavari Ghrita 10 ml BD for 5 months(12‐14 weeks onwards to 34 weeks);Iron capsule (ferrous ascorbate 100 mg,folic acid 1.5 mg)OD for 6 months (12 weeks onwards till delivery); calcium tablet(calcium carbonate and vit. D3) 500 mg OD for 6 months (12 weeks onwards till delivery) Control Intervention1: Routine antenatal care: Iron capsule (ferrous ascorbate 100 mg,folic acid 1.5 mg)OD for 6 months (12 weeks onwards till delivery); calcium tablet(calcium carbonate and vit. D3) 500 mg OD for 6 months (12 weeks onwards till delivery) CONDITION: PRIMARY OUTCOME: Evaluate the effect of oral administration of Shatavari ghrita during pregnancy on fetal outcome w.s.r. to birth weightTimepoint: Baby fetal weight by USG; Birth weight will be noted at the time of delivery and on 10th after delivery; APGAR score SECONDARY OUTCOME: Evaluate the effect of oral administration of Shatavari ghrita in garbhini i.e. to minimize the complications of pregnancyTimepoint: Every 15th day in 4th to 6th month;every 8th day in 7th to 9th month; Gestational age at the time of labour; Mode of delivery; Duration of labour INCLUSION CRITERIA: Primi and second gravida with gestational age 12 to 14 weeks;able and willing to participate and provide signed informed consent